Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa neoadjuvant local and intratumoral PTS injection in early breast cancer
ChiCTR-ONC-12002946Phase 2Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Feb 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of para-toluenesulfonamide in breast cancer, sponsored by Peking University Cancer Hospital & Institute. Primary endpoints: Histologic and pathologic changes in tumor tissue and adjacent normal tissue and Efficacy evaluation by RECIST and WHO criteria. Started Feb 2002; status: completed.
02
Drugs
para-toluenesulfonamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-ONC-12002946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002946.